ArticleEnvironmental science and pollution research international2017
Isolation and identification of antifungal peptides from Bacillus amyloliquefaciens W10.
Article in Environmental science and pollution research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 46 citations in OpenAlex.
- Volatile Organic Compounds Produced byFoods (Basel, Switzerland) · 2024Article
- Antifungal potential of lipopeptides produced by theMicrobiology spectrum · 2024Article
- Lichenysin-like Polypeptide Production byMicroorganisms · 2023Article
- Suppression of Fusarium Wilt in Watermelon byJournal of fungi (Basel, Switzerland) · 2023Article
- Metabolomic Insights of Biosurfactant Activity fromInternational journal of molecular sciences · 2023Article
- Antifungal Peptide P852 Controls Fusarium Wilt in Faba Bean (Antioxidants (Basel, Switzerland) · 2022Article
- Biosurfactant from Bacillus sp. A5F Reduces Disease Incidence of Sclerotinia sclerotiorum in Soybean Crop.Current microbiology · 2022Article
- Isolation of the Novel StrainPlants (Basel, Switzerland) · 2022Article
- Article
- A Thermotolerant MarineMarine drugs · 2021Article
- Activity and Mechanism of Action of Antifungal Peptides from Microorganisms: A Review.Molecules (Basel, Switzerland) · 2021Review
- Biocontrol Ability and Mechanism of a Broad-Spectrum Antifungal StrainFrontiers in microbiology · 2021Article
- Silver nanoparticles from insect wing extract: Biosynthesis and evaluation for antioxidant and antimicrobial potential.PloS one · 2021Article
- Enhanced production of antifungal lipopeptide iturin A by Bacillus amyloliquefaciens LL3 through metabolic engineering and culture conditions optimization.Microbial cell factories · 2019Article
- Antifungal Activity of Lipopeptides FromFrontiers in microbiology · 2018Article
- Biofilms in the Food Industry: Health Aspects and Control Methods.Frontiers in microbiology · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antifungal metabolites produced by Bacillus sp. W10, which was previously isolated from the tomato rhizosphere, were investigated. Strain W10 was identified as Bacillus amyloliquefaciens by analysis of its 16S rDNA and gyrB gene partial sequences. PCR analysis showed the presence of fenB, sfp, and ituD genes, coding for fengycin, surfactin, and iturin, respectively. A novel small antifungal peptide, designated 5240, produced by this strain was isolated by ammonium sulfate precipitation and Superdex 200 gel filtration chromatography. The 5240 peptide was stable at 100 °C for 20 min and remained active throughout a wide pH range (4-10). The antagonistic activity was not affected by protease K and trypsin. The purified 5240 peptide exhibited a broad inhibitory spectrum against various plant pathogenic fungi and was identified as iturin A (C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.